CHMP recommends GSK’s Blenrep approval for multiple myeloma treatment
The European Commission’s decision for approval is anticipated in the third quarter of this year.
Approvals
EC grants orphan drug designation to Dyne Therapeutics’ DMD therapy
Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers
Genmab’s Tivdak approved in Japan for advanced cervical cancer
FDA approves GSK’s Blujepa for uncomplicated UTIs
EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy
FDA grants ODD status to Zai Lab’s lung cancer treatment
FDA approves Mesoblast’s Ryoncil for SR-aGvHD treatment
